Periodontal disease is one the most common chronic conditions affecting patients and populations. Accordingly, the disease is initiated by etiologic infectious agents (bacteria) that stimulate both local and systemic inflammatory responses. These responses culminate in the local tissue destruction characteristic of periodontitis and may contribute to poorer systemic health outcomes. Long-term control of the infectious and inflammatory components of the disease remains the principal goal of maintenance therapy for patients at risk. This presentation will review the current model of infection and inflammation central to the pathogenesis of periodontal disease and discuss the overall evidence on mechanical as well as adjunctive pharmacologic (antimicrobial and host modulatory) therapies for maintenance patients. In addition, emerging data that maintenance procedures may improve biomarkers associated with systemic diseases such as cardiovascular disease and diabetes will be introduced.
David W. Paquette, DMD, MPH, DMSc, is an associate professor, graduate program director in periodontology and assistant dean for advanced dental education at the University of North Carolina at Chapel Hill. He completed his graduate and postgraduate studies at Harvard University School of Dental Medicine. Dr Paquette is active in many international and national organizations, including the International Association for Dental Research and the American Academy of Periodontology. Dr Paquette’s major research interests include clinical trials, novel interventions for periodontal disease, and the interplay between periodontal disease and systemic conditions, in particular cardiovascular disease and obesity. Dr Paquette is a diplomate of the American Board of Periodontology and maintains a private practice specializing in periodontics in Chapel Hill.
Approximate Running Time: 45 minutes